These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Real-World Experience Using Intravitreal Brolucizumab Alone or in Combination with Aflibercept in the Management of Neovascular Age-Related Macular Degeneration. Mehta N; Fong RD; Wilson M; Moussa K; Emami-Naeini P; Moshiri A; Yiu G; Park SS Clin Ophthalmol; 2023; 17():657-665. PubMed ID: 36880020 [TBL] [Abstract][Full Text] [Related]
33. Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular Degeneration. Nguyen QD; Das A; Do DV; Dugel PU; Gomes A; Holz FG; Koh A; Pan CK; Sepah YJ; Patel N; MacLeod H; Maurer P Ophthalmology; 2020 Jul; 127(7):963-976. PubMed ID: 32107066 [TBL] [Abstract][Full Text] [Related]
34. Short-term real-world outcomes following intravitreal brolucizumab for neovascular AMD: SHIFT study. Bulirsch LM; Saßmannshausen M; Nadal J; Liegl R; Thiele S; Holz FG Br J Ophthalmol; 2022 Sep; 106(9):1288-1294. PubMed ID: 33846161 [TBL] [Abstract][Full Text] [Related]
35. Brolucizumab for Wet Age-Related Macular Degeneration: One-Year Real-World Experience from a Tertiary Center. Scupola A; Carlà MM; Boselli F; Giannuzzi F; De Filippis A; Fossataro C; Minnella AM; D'Amico G; Coppola G; Savastano MC; Sammarco MG; Rizzo S Ophthalmologica; 2023; 246(1):58-67. PubMed ID: 36843038 [TBL] [Abstract][Full Text] [Related]
36. Visual outcomes of intraocular inflammation after brolucizumab injection in Japanese patients with neovascular age-related macular degeneration. Hirono K; Maruyama-Inoue M; Yanagi Y; Kadonosono K PLoS One; 2024; 19(4):e0302295. PubMed ID: 38635732 [TBL] [Abstract][Full Text] [Related]
37. [Real-life experiences with Brolucizumab in recalcitrant neovascular age-related macular degeneration]. Book M; Ziegler M; Rothaus K; Faatz H; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D Ophthalmologe; 2022 Mar; 119(3):258-264. PubMed ID: 34351479 [TBL] [Abstract][Full Text] [Related]